Actively Recruiting
EUS-guided Entero-biliary Anastomosis for Therapeutic Access in Benign Biliary Obstructions
Led by Hospital del Rio Hortega · Updated on 2025-03-11
50
Participants Needed
1
Research Sites
265 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Background: Transpapillary EUS-BD (rendezvous/antegrade) is gaining acceptance in BBO. The potential of transmural EUS-BD (hepaticogastrostomy/choledochoduodenostomy) in complex BBO warrants study. Aims: To assess feasibility and efficacy of TEA using transmural covered self-expandable metal-stents (cSEMS) to provide interval biliary drainage and create TAF for biliary endotherapy under cholangioscopy or fluoroscopy in BBO not amenable to ERCP.
CONDITIONS
Official Title
EUS-guided Entero-biliary Anastomosis for Therapeutic Access in Benign Biliary Obstructions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Consecutive patients 18 years or older
- Diagnosed with benign biliary obstruction
- ERCP failed or ERCP cannot be performed due to surgically altered anatomy
You will not qualify if you...
- Refusal to sign the informed consent
- Malignant biliary obstruction
- Uncorrectable coagulopathy (INR >1.5) or low platelets (<50,000/mm3)
- Unable to tolerate sedation needed for the procedure
- Pregnancy or lactation
- Unable to follow-up during the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital Rio Hortega
Valladolid, Spain, 47012
Actively Recruiting
Research Team
C
Carlos Maroto Martín, PI
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here